These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2473246)

  • 1. [Safety of long-term therapy with a combination of various anti-arrhythmia agents].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Klin Med (Mosk); 1989 Mar; 67(3):79-82. PubMed ID: 2473246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-arrhythmic activity of atropine, ritmilen, obsidan and cordarone in patients with ventricular allorhythmia].
    Antiu'fev VF; Arkhipov MV
    Klin Med (Mosk); 1989 Jun; 67(6):112-7. PubMed ID: 2476585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in using anti-arrhythmia preparations of groups I and III in patients with arrhythmia resistant to therapy].
    Abdalla A; Mazur NA
    Kardiologiia; 1988 Mar; 28(3):51-4. PubMed ID: 2454343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic effectiveness of allapinin in ventricular arrhythmia in patients with circulatory failure].
    Naumov VG; Blinov SI; Khodzhakuliev BG; Vangeli RS
    Ter Arkh; 1988; 60(8):39-41. PubMed ID: 2465582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative clinical study of the effectiveness of the new anti-arrhythmia agents, trimecaine and pyrromecaine].
    Pavlova TS; Riabokon' OS; Ivanova LA; Sumarokov AB
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):67-72. PubMed ID: 6196040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of combinations of group I anti-arrhythmia drugs in patients with refractory arrhythmias].
    Abdalla A; Mazur NA; Ivanova LA; Sumarokov AV
    Kardiologiia; 1988 Feb; 28(2):42-6. PubMed ID: 2453699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with the combined use of 1st- and 2d-group anti-arrhythmic preparations in patients with refractory arrhythmia].
    Abdalla A; Mazur NA
    Klin Med (Mosk); 1988 Jun; 66(6):40-3. PubMed ID: 2460667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of various anti-arrhythmia drugs on serum digoxin level].
    Halawa B; Mazurek W
    Wiad Lek; 1981 Apr; 34(7):537-40. PubMed ID: 6168119
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-arrhythmic effect of cordaron in patients with unstable stenocardia and myocardial infarction].
    Dobrotvorskaia TE; Mustafaev FM; Abdullaeva TI; Matsueva NL
    Klin Med (Mosk); 1989 Nov; 67(11):40-3. PubMed ID: 2483189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Propafenon, a new anti-arrhythmic drug (author's transl)].
    Aldor E; Heeger H
    Dtsch Med Wochenschr; 1976 Sep; 101(36):1318-22. PubMed ID: 60209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacodynamics of anti-arrhythmia preparations and their different combinations when administered intravenously].
    Abdalla A; Mazur NA; Iavorskaia NV; Kheĭmets GI; Chikovani SI; Potekhin EG
    Ter Arkh; 1992; 64(8):20-5. PubMed ID: 1279828
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the anti-arrhythmic effectiveness of ethacizine, ethmozine, cordarone, mexitil and ritmilen in elderly patients with ventricular extrasystole].
    Korkushko OV; Shatilo VB
    Kardiologiia; 1990 Nov; 30(11):23-5. PubMed ID: 1707997
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
    Piotrovskiĭ VK; Blagodatskikh SV; Metelitsa VI; Smirnov VK; Gorshkov VA
    Farmakol Toksikol; 1985; 48(4):83-6. PubMed ID: 2412887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic and preventive effect of oral lidocaine in extrasystole].
    Nikolov G; Zlatereva N; Shabani R; Tashkova N
    Vutr Boles; 1982; 21(6):32-5. PubMed ID: 6187132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various aspects of the anti-arrhythmia action of trimecaine and its effect on hemodynamics].
    Kostin IaV; Oleĭnikov VE; Sernov LN; Tatarchenko IP; Gendenshteĭn EI
    Farmakol Toksikol; 1984; 47(1):47-50. PubMed ID: 6200357
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics and pharmacodynamics of the new Russian anti-arrhythmia drug allapinin].
    Abdalla A; Rulin VA; Mazur NA; Sumarokov AB; Chikovani SI
    Kardiologiia; 1989 Jan; 29(1):32-6. PubMed ID: 2471868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-arrhythmia effect of prolecophen in patients with extrasystole in comparison with other anti-arrhythmia drugs].
    Abdalla A; Mazur NA; Sumarokov AB
    Kardiologiia; 1989 Oct; 29(10):97-9. PubMed ID: 2482381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of the effectiveness of allapinin in patients with frequent and stable extrasystole].
    Abdalla A; Mazur NA; Sumarokov AB; Iavorskaia NV
    Kardiologiia; 1988 Nov; 28(11):95-7. PubMed ID: 2466144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effectiveness of neogilurytmal, novocainamide, ethmozin, disopyramide and ethacizin in supraventricular extrasystole].
    Shpektor AV; Gorshkov VA; Mamaev VI; Sherashov VS; Kurakina TI
    Sov Med; 1986; (12):96-7. PubMed ID: 2436318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.